| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 283.65M | 79.28% |
| Operating expense | — | — |
| Net income | -555.29M | -5.98% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JWCTF returned -69.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -43.8% |
| 1 year | -69.4% |
| 5 years | -83.9% |
| All-time high | $2.50 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in JWCTF would be worth today ›No. JW (Cayman) Therapeutics Co. Ltd has not paid a dividend in the past 12 months.
JW (Cayman) Therapeutics Co. Ltd is part of the Healthcare sector.
JW (Cayman) Therapeutics Co. Ltd has a market cap of 147.89M USD, based on the latest quote.